Top-selected medical devices trusted by oncology centers globally for safe and efficient cancer therapy delivery.
A Huber Straight Needle is a specially designed, non-coring needle used to access implantable venous port systems — also known as port-a-caths — in cancer patients. Unlike conventional hypodermic needles, the Huber needle features a uniquely deflected tip that penetrates the silicone septum of an implanted port without removing a core of material. This design is critical for preserving the port's integrity over hundreds of access cycles.
In oncology treatment, patients often require prolonged and repeated intravenous administration of chemotherapy agents, immunotherapy drugs, blood products, nutritional supplements, or contrast media. The Huber Straight Needle provides a reliable, safe, and minimally traumatic pathway for these repeated infusions, dramatically reducing the risk of port damage, infection, and patient discomfort.
The defining feature of the Huber needle is its non-coring geometry. When a standard needle punctures a silicone septum, it cuts out small fragments — cores — which can migrate into the bloodstream and cause complications. The Huber needle's angled bevel simply displaces the silicone, allowing it to reseal after removal. For a cancer patient accessing the same port monthly or even weekly, this self-sealing quality extends the operational lifespan of the port to thousands of punctures.
Huber needles come in two principal configurations: straight and angled (90°). The Huber Straight Needle is typically preferred for shorter dwell times — single-session infusions, blood draws, or contrast injections during imaging-guided procedures. Its profile allows straightforward insertion and removal, making it highly practical in outpatient oncology clinics, infusion suites, and day-hospital settings. The straight format is also favored for pediatric oncology patients where port depth is shallower and dwell comfort is paramount.
Specially angled bevel preserves the silicone septum, enabling thousands of repeated port accesses without degradation.
Engineered for high-pressure infusion of cytotoxic drugs with minimal risk of extravasation or needle dislodgment.
Manufactured under ISO 13485 quality systems and certified to international standards for global clinical deployment.
Deployed across 120+ countries in leading oncology hospitals, cancer centers, and ambulatory infusion facilities.
The implantable port access needle market is expanding rapidly as cancer incidence rises and long-term vascular access solutions become standard of care worldwide.
The global vascular access device market, including Huber needles and port systems, is projected to exceed USD 6.5 billion by 2028, driven by rising cancer prevalence and expanding ambulatory chemotherapy programs.
Over 20 million new cancer cases are diagnosed annually worldwide. The majority of patients receiving intravenous chemotherapy benefit from implantable ports accessed via Huber straight needles, creating consistent high-volume clinical demand.
North America and Europe dominate the market, but Asia-Pacific is the fastest growing region, with China, India, and Southeast Asia investing heavily in oncology infrastructure and standardizing port-based chemotherapy protocols.
China has emerged as a leading manufacturer and exporter of Huber needles and port access systems, combining ISO-certified production with competitive pricing — enabling global distributors and healthcare systems to maintain reliable supply chains.
TEAMSTAND is the appointed supplier for the Australian Government Department of Health (AGDH) and California Department of Public Health (CDPH), serving over 120 countries with trusted oncology-grade medical devices including the full Huber needle product range.
The oncology access device industry is evolving rapidly, with new engineering and clinical innovations reshaping how Huber straight needles are designed, used, and integrated into cancer care workflows.
Next-generation Huber needles increasingly incorporate passive safety mechanisms — such as automatic needle retraction shields — to minimize needlestick injuries to oncology nurses and technicians handling cytotoxic agents. These safety-engineered devices are becoming mandatory in many healthcare systems.
Modern oncology departments are adopting ultrasound guidance for port access in difficult anatomies. Huber needle design is evolving to include echogenic surface features or integrated depth markers that improve real-time visualization under ultrasound, reducing missed punctures and procedure time.
Engineering advances focus on minimizing dead space volume and incorporating anti-reflux valve mechanisms, reducing drug waste, preventing blood backflow, and decreasing catheter occlusion rates — all critical concerns in long-term oncology port management.
Port-related bloodstream infections (CRBSI) are a significant complication in cancer patients. R&D efforts are integrating antimicrobial coatings — including silver nanoparticles and chlorhexidine-based surfaces — into Huber needle hubs and tubing to reduce infection risk over extended dwell periods.
Increased investment in pediatric oncology is driving demand for smaller-gauge Huber straight needles (24G–26G) with pediatric-specific ergonomic wings and shorter lengths, ensuring gentle, accurate port access for young cancer patients with minimal trauma.
Leading manufacturers, including Chinese exporters, are adopting AI-based visual inspection systems on Huber needle production lines to detect micro-defects in bevel geometry, tip sharpness, and tubing integrity — ensuring zero-defect delivery to hospitals worldwide.
Huber straight needles serve a broad spectrum of clinical scenarios beyond standard chemotherapy — their precision design enables multiple critical oncology workflows.
Primary use: delivering cytotoxic chemotherapy agents through implanted ports in breast, lung, colon, and hematologic cancers. Straight needle geometry is ideal for single-day IV push or short-infusion protocols.
Oncology patients require frequent complete blood counts (CBC) and blood chemistry monitoring. Huber straight needles provide reliable port access for blood draws, reducing peripheral venipuncture burden on fragile veins.
Modern immuno-oncology agents (checkpoint inhibitors, monoclonal antibodies) are delivered via IV infusion. Huber needle port access ensures consistent, uninterrupted administration of these high-value biologics.
Cancer patients with gastrointestinal complications or severe cachexia receive total parenteral nutrition (TPN) via port. Huber straight needles enable clean, secure access for high-osmolarity nutritional solutions.
High-pressure rated Huber needle systems are used for power-injection of contrast agents during CT and MRI staging scans, allowing power injector compatibility without replacing the port or using peripheral access.
Oncology clinical trials require precise, reproducible drug delivery. Huber straight needles ensure standardized port access, minimizing variability in drug administration timing and volume in investigational therapy protocols.
To become a Top 10 medical supplier in China — delivering world-class oncology devices including Huber straight needles that are trusted by hospitals and cancer centers in over 120 countries.
For your health. We are committed to improving and extending people's lives through innovative, reliable, and affordable medical products — with cancer care at the heart of everything we do.
SHANGHAI TEAMSTAND CORPORATION, Headquartered in Shanghai, is a professional supplier of medical products and solutions. "For your health", deeply rooted in everyone's hearts of our team, we focus on innovation and provides healthcare solutions that improves and extends people's lives. We are both a manufacturer and exporter. With over 10 years' experience in healthcare supply, two factories in Wenzhou and Hangzhou, over 100 partner manufacturers, which enable us to provide our customers with widest selection of products, consistently low pricing, excellent OEM services and on-time delivery for customers.
Relying on our own advantages, we have so far become the supplier appointed by Australian Government Department of Health (AGDH) & California Department of Public Health (CDPH) and ranked in Top 5 Players of Infusion, Injection & paracentesis products in China.
Up to 2026, we had delivered products to our customers in over 120 countries, such as USA, EU, Middle East, Southeast Asia, etc., annual turnover is over USD 300 million.
Our responsiveness and commitment to our customers' needs is evident in our actions every day. This is who we are and the reason why customers choose us as their trusted, integrated business partner.
With over 10 years' experience in medical industry, we have exported to USA, EU, Middle East, Southeast Asia etc total more than 120 countries. And we have gained good reputation among all of these customers for good service and competitive price.
Headquartered in Shanghai, the biggest and modernized city in China, TEAMSTAND invests 2 factories in Shandong and Jiangsu, and cooperates with over 100 factories in China. "Top 10 medical supplier in China" is our goal. It is believed that, with the professional workers, good management, advanced equipment and strict quality control system, we can do better and better in the future.
Welcome all friends and customers all over the world in medical industry to contact us!
Take a virtual tour of our manufacturing facilities to see how TEAMSTAND produces world-class Huber needles and oncology medical devices under strict quality control.
What makes TEAMSTAND the preferred partner for oncology-grade Huber needles and vascular access devices across global healthcare markets.
Quality is the most important requirement for medical products. To ensure only the highest quality products, we work with the most qualified factories. Most of our products have CE, FDA certification, we guarantee your satisfaction on our entire product line.
We offer complete support from the beginning. Not only do we offer a wide variety of products for different demands, but our professional team can assist in personalized medical solutions. Our bottom line is to provide customer satisfaction.
Our goal is to achieve long-term cooperation. This is accomplished not only through quality products, but also striving to provide the best pricing to our customers.
We are eager to help you with whatever you may be looking for. Our response time is quick, so feel free to contact us today with any questions. We look forward to serving you.
So that you can meet your desires, please really feel cost-free to contact us. You could send us emails and call us straight. Our team specializes in Huber straight needle solutions and comprehensive oncology medical supplies.
Explore our comprehensive range of oncology-grade disposable and reusable medical devices for cancer treatment workflows.
Medical Disposable Silicone Breathing Anesthesia Circuit Price
Disposable medical supplies double triple lumen Extn tube with needle free valve
Nylon Reusable Adult Blood Pressure Cuff NIBP Cuff
Medicial coronary ptca balloon dilatation catheter
Hospital Medical Use Platelet Rich Plasma Prp Kit
Hospital Adult Child Disposable Medical PVC Oxygen Anesthesia Mask
Medical Supply Urology Cystoscopy Set/Cystoscope Instruments
0.25ml 0.5ml 1ml Mini Micro Capillary Blood Collection Test Tube